[{"NetIncomeLoss_1_Q3_USD":-734266.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":650031.0,"NetCashProvidedByUsedInInvestingActivities_2_Q3_USD":-143750000.0,"InterestIncomeOther_2_Q3_USD":3387.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":737653.0,"GeneralAndAdministrativeExpense_2_Q3_USD":738653.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ProceedsFromRelatedPartyDebt_2_Q3_USD":80000.0,"Liabilities_0_Q3_USD":974031.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1344680.0,"SharesIssuedPricePerShare_0_Q3_USD":18.0,"PaymentsOfStockIssuanceCosts_2_Q3_USD":166063.0,"StockIssuedDuringPeriodValueOther_1_Q3_USD":140359937.0,"NetCashProvidedByUsedInFinancingActivities_2_Q3_USD":145583937.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q3_USD":4875000.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":143753387.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q3_pure":0.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q3_USD":1344680.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_Q3_pure":0.5,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q3_USD":650031.0,"FederalDepositInsuranceCorporationPremiumExpense_2_Q3_USD":250000.0,"CommonStockValue_0_Q3_USD":91.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_Q3_USD":3390063.0,"AssetsCurrent_0_Q3_USD":1745315.0,"PrepaidExpenseCurrent_0_Q3_USD":400635.0,"RepaymentsOfRelatedPartyDebt_2_Q3_USD":80000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"NetIncomeLoss_2_Q3_USD":-735266.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"AdditionalPaidInCapital_0_Q3_USD":5734817.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_2_Q3_USD":10000.0,"BusinessAcquisitionSharePrice_0_Q3_USD":10.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_0_Q3_USD":9.2,"NetCashProvidedByUsedInOperatingActivities_2_Q3_USD":-489257.0,"TangibleAssetImpairmentCharges_2_Q3_USD":5000001.0,"MarketableSecurities_0_Q3_USD":143753387.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-735266.0,"StockholdersEquity_0_Q3_USD":5000001.0,"ProceedsFromOtherEquity_2_Q3_USD":140875000.0,"DeferredTaxAssetsValuationAllowance_0_Q3_USD":154000.0,"BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_0_Q3_pure":0.6,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":145498702.0,"PreferredStockValue_0_Q3_USD":null,"InvestmentIncomeInterest_2_Q3_USD":3387.0,"OperatingIncomeLoss_1_Q3_USD":-737653.0,"OperatingIncomeLoss_2_Q3_USD":-738653.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_Q3_USD":139524670.0,"DeferredTaxAssetsNet_0_Q3_USD":154000.0,"ProductionTaxExpense_2_Q3_USD":3000.0,"Assets_0_Q3_USD":145498702.0,"IncreaseDecreaseInPrepaidExpense_2_Q3_USD":400635.0,"Ticker":"NUVB","CIK":"1811063","name":"PANACEA ACQUISITION CORP","OfficialName":"Nuvation Bio Inc. Class A Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1238973430.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201116"}]